Table 2.
Availability of essential medicines in Kilifi County based on Kenya's essential medicines list for mental illnesses
| Antipsychotics | Formulation | Dosage | Available in Kilifi County |
|---|---|---|---|
| Chlorpromazine HCl | Injection | (a) 25 mg/ml (2 ml amp) | Yes |
| Tablet | (b) 50 mg | No | |
| (c) 100 mg 4 | Yes | ||
| Flupentixol decanoate | Injection (oily, depot) | 20 mg/ml (2 ml amp) | No |
| Fluphenazine decanoate | Injection (oily, depot) | 25 mg/1 ml amp | Yes |
| Haloperidol | (a) Injection | 5 mg/1 ml amp | Yes |
| (b) Oral liquida | 2 mg/ml | ||
| (c) Tablet (scored) | 5 mg | Yes | |
| Olanzapineb | PFI | 10 mg vial | No |
| Quetiapine | Tablet | 200 mg (scored | No |
| Zuclopenthixol acetate | Injection (oily) | 50 mg/ml (2 ml amp) | No |
| Injection (depot, oily)c | 200 mg/1 ml amp | No | |
| Specialist list | |||
| Chlorpromazine HCl | Injection | 25 mg/ml (2 ml amp) | Yes |
| Clozapine | Tablet (scored) | (a) 25 mg | Yes |
| (b) 100 mg | Yes | ||
| Haloperidol | Injection | (a) 5 mg/1ml amp | No |
| Tablet (scored) | 5 mg | Yes | |
| Risperidone | Tablet | 2 mg (scored) | No |
| Medicines used in depressive disorders | |||
| Amitriptyline HCl | Tablet | 25 mg | Yes |
| Fluoxetine | Tablet (scored) | 20 mg (as HCl) | Yes |
| Specialist list | |||
| Fluoxetined | Tablet (scored) | 20 mg (as HCl) | No |
| Venlafaxine | Capsule | 75 mg (as HCl) | No |
| Medicines used in bipolar disorders | |||
| Carbamazepine | Tablet | 200 mg (cross-scored) | No |
| Valproic acid (sodium valproate) | Tablet (enteric-coated) | (a) 200 mg | Yes |
| (b) 500 mg | No | ||
| Specialist list | |||
| Lithium carbonate | Tablet | 400 mg (modified release) | No |
| Medicines used in anxiety disorders | |||
| Bromazepame | Tablet (scored) | 3 mg | No |
| Medicines used in obsessive compulsive disorders | |||
| Clomipramine HCl | Capsule | 25 mg | No |
| Medicine used in disorders due to psychoactive substance abuse | |||
| Diazepamf | Tablet | 5 mg | Yes |
| Nicotine | Chewing gum | (a) 2 mg | No |
| (b) 4 mg | No | ||
| Specialist listg | |||
| B vitamins, high potency | Injection IM | 7 ml (in 2 amps)h | Yes |
| Injection IV | 10 mL (2 × 5 ml amps)i | Yes | |
| Buprenorphine + naloxone (both as HCl) | Tablet (sublingual) | (a) 2 mg + 500 mg | |
| (b) 8 mg + 2 mg | |||
| Methadone HCl | Oral liquid | 5 mg/ml (concentrate) | No |
| Naltrexone HCl | Tablet | 50 mg | No |
| Medicine used in attention deficit hyperactivity disorder | |||
| Methylphenidate | Tablet | 10 mg | Yes |
Drops with dosing pipette.
Use only in patients refractory to, or intolerant of, 1st generation antipsychotic.
Use only in patients refractory to, or unable to tolerate, other antipsychotics.
Only use in patients >8 years.
Only use in anxiety with agitation.
Only use in the management of alcohol dependence.
Use under close supervision within substance dependency treatment programmes.
Ascorbic acid 500 mg, nicotinamide 160 mg, pyridoxine hydrochloride 50 mg, riboflavin 4 mg, thiamine hydrochloride 250 mg/7 ml.
Ascorbic acid 500 mg, nicotinamide 160 mg, pyridoxine hydrochloride 50 mg, riboflavin 4 mg, thiamine hydrochloride 250 mg/10 ml.